Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in IMVT — Immunovant, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in IMVT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$16,405,279
+$60,880 QoQ
Shares Held
660,438
+2.7% QoQ
Ownership
0.322%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,185,699,337 across 288 Biotechnology names. IMVT ranks #71 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMVT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,405,279 660,438
2025-12-31 $16,344,399 642,974
2025-09-30 $9,360,819 580,696
2025-06-30 $10,578,336 661,146
2025-03-31 $10,708,799 626,612
2024-12-31 $13,981,228 564,442
2024-09-30 $15,749,779 552,430
2024-06-30 $12,174,914 461,171
2024-03-31 $14,283,734 442,084
2023-12-31 $18,414,180 437,080
2023-09-30 $14,866,143 387,240
2023-06-30 $7,856,311 414,144
2023-03-31 $6,025,123 388,467
2022-12-31 $6,863,108 386,654
2022-09-30 $1,701,760 304,975
2022-06-30 $1,190,014 305,132
2022-03-31 $1,642,613 298,115
2021-12-31 $2,478,740 290,932
2021-09-30 $2,340,894 269,378
2021-06-30 $3,534,988 334,436
2021-03-31 $5,317,051 331,487
2020-12-31 $14,031,321 303,774
2020-09-30 $8,747,987 248,593
2020-06-30 $3,791,368 155,703